OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
Clinical trial NCT00577031 · COMPLETED
Trial details
- NCT number
- NCT00577031
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2011-08-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.